Enbrel Biosimilar Gets Green Light
Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.
Cryotherapy a Cool Trend After All?
Whole-body cryotherapy may not be so cool after all, according to the US Food and Drug Administration (FDA).
Find A Prescription Treatment For Moderate or Severe RA
Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Learn About an FDA Approved Treatment for Rheumatoid Arthritis
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Three Rare Diseases Get New Treatment Option
The US Food and Drug Administration (FDA) has approved a new treatment option for three rare diseases.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
FDA Approves First Biosimilar Etanercept
The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept.
Are 'Generic' Biologics the Same as the 'Brand'?
Generic versions of often expensive brand-name biologic medications appear safe and effective on the whole, a new study found.